Abstract
Survival of Escherichia coli O157:H7 was investigated using a dynamic gastrointestinal model. A high bacterial mortality was observed in the stomach and duodenum. In contrast, bacteria grew in the distal parts of the small intestine. The coadministration of Saccharomyces cerevisiae CNCM I-3856 led to a significant reduction of bacterial resumption, maybe through ethanol production.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibiosis*
-
Colony Count, Microbial
-
Escherichia coli O157 / drug effects*
-
Escherichia coli O157 / genetics
-
Escherichia coli O157 / growth & development*
-
Ethanol / metabolism
-
Ethanol / pharmacology
-
Gastrointestinal Tract / microbiology*
-
Humans
-
Microbial Viability
-
Probiotics / administration & dosage*
-
Probiotics / pharmacology*
-
Saccharomyces cerevisiae / growth & development*
-
Saccharomyces cerevisiae / metabolism